Cargando…
Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use
BACKGROUND: Electronic monitoring of inhaled asthma therapy is suggested as the ‘gold standard’ for measuring patterns of medication use in clinical trials. The SmartTurbo (Adherium (NZ) Ltd, Auckland, New Zealand) is an electronic monitor for use with a turbuhaler device (AstraZeneca, UK). The aim...
Autores principales: | Pilcher, Janine, Shirtcliffe, Philippa, Patel, Mitesh, McKinstry, Steve, Cripps, Terrianne, Weatherall, Mark, Beasley, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653861/ https://www.ncbi.nlm.nih.gov/pubmed/26629345 http://dx.doi.org/10.1136/bmjresp-2015-000097 |
Ejemplares similares
-
Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma
por: Fingleton, James, et al.
Publicado: (2017) -
Tolerability of Nasal Delivery of Humidified and Warmed Air at Different Temperatures: A Randomised Double-Blind Pilot Study
por: Bibby, Susan, et al.
Publicado: (2016) -
Validation of a metered dose inhaler electronic monitoring device: implications for asthma clinical trial use
por: Pilcher, Janine, et al.
Publicado: (2016) -
Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study
por: Makhecha, Sukeshi, et al.
Publicado: (2020) -
Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Bardsley, George, et al.
Publicado: (2018)